TY - STD TI - Dimebon Disappoints in Phase 3 Trial. [http://www.alzforum.org/new/detail.Asp?id=2387] UR - http://www.alzforum.org/new/detail.Asp?id=2387 ID - ref1 ER - TY - STD TI - Pfizer and Medivation Announce Results from two Phase 3 Studies in Dimebon (Latrepirdine) Alzheimer's Disease Clinical Development Program. [http://investors.medivation.com/releasedetail.Cfm?ReleaseID=448818] UR - http://investors.medivation.com/releasedetail.Cfm?ReleaseID=448818 ID - ref2 ER - TY - JOUR AU - Doody, R. S. AU - Gavrilova, S. I. AU - Sano, M. AU - Thomas, R. G. AU - Aisen, P. S. AU - Bachurin, S. O. AU - Seely, L. AU - Hung, D. PY - 2008 DA - 2008// TI - Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled study JO - Lancet VL - 372 UR - https://doi.org/10.1016/S0140-6736(08)61074-0 DO - 10.1016/S0140-6736(08)61074-0 ID - Doody2008 ER - TY - JOUR AU - Bachurin, S. AU - Bukatina, E. AU - Lermontova, N. AU - Tkachenko, S. AU - Afanasiev, A. AU - Grigoriev, V. AU - Grigorieva, I. AU - Ivanov, Y. AU - Sablin, S. AU - Zefirov, N. PY - 2001 DA - 2001// TI - Antihistamine agent dimebon as a novel neuroprotector and a cognition enhancer JO - Ann NY Acad Sci VL - 939 UR - https://doi.org/10.1111/j.1749-6632.2001.tb03654.x DO - 10.1111/j.1749-6632.2001.tb03654.x ID - Bachurin2001 ER - TY - JOUR AU - Lermontova, N. N. AU - Redkozubov, A. E. AU - Shevtsova, E. F. AU - Serkova, T. P. AU - Kireeva, E. G. AU - Bachurin, S. O. PY - 2001 DA - 2001// TI - Dimebon and tacrine inhibit neurotoxic action of beta-amyloid in culture and block L-type Ca2+ channels JO - Bull Exp Biol Med VL - 132 UR - https://doi.org/10.1023/A:1017972709652 DO - 10.1023/A:1017972709652 ID - Lermontova2001 ER - TY - JOUR AU - Grigor'ev, V. V. AU - Dranyi, O. A. AU - Bachurin, S. O. PY - 2003 DA - 2003// TI - Comparative study of action mechanisms of dimebon and memantine on AMPA- and NMDA-subtypes glutamate receptors in rat cerebral neurons JO - Bull Exp Biol Med VL - 136 UR - https://doi.org/10.1023/B:BEBM.0000017097.75818.14 DO - 10.1023/B:BEBM.0000017097.75818.14 ID - Grigor'ev2003 ER - TY - JOUR AU - Bachurin, S. O. AU - Shevtsova, E. P. AU - Kireeva, E. G. AU - Oxenkrug, G. F. AU - Sablin, S. O. PY - 2003 DA - 2003// TI - Mitochondria as a target for neurotoxins and neuroprotective agents JO - Ann NY Acad Sci VL - 993 UR - https://doi.org/10.1111/j.1749-6632.2003.tb07541.x DO - 10.1111/j.1749-6632.2003.tb07541.x ID - Bachurin2003 ER - TY - STD TI - Jeffrey S: Dimebon disappoints: is there hope for novel Alzheimer's agent?. Medscape Medical News. [http://www.Google.com]:MedscapeDimebon UR - http://www.Google.com ID - ref8 ER -